Insulin Sensitizers May Help Ward Off Colorectal Cancer for Diabetes Patients

Insulin sensitizers, such as metformin and thiazolidinediones, may help prevent colon polyps from developing in type 2 diabetes patients, according to research presented at the American Association of Clinical Endocrinologists meeting and published in MedPage Today.

Advertisement

In a retrospective study of more than 132,000 VA patients with type 2 diabetes, researchers found patients taking either metformin or thiazolidinediones had a lower risk of having colorectal polyps. Other medications, including aspirin and non-steroidal anti-inflammatory drugs, were associated with a lower risk of polypectomy.

The researchers also found risk factors for developing polyps in type 2 diabetes patients were increasing age, male gender, non-Hispanic white race and smoking, according to the news report.

Read the news report about insulin sensitizers and colon polyps.

Read other coverage about colorectal cancer:

– Two Samples in FIT Testing Improves Diagnostic Yield Without Affecting Attendance

– Study: Gastroenterologists More Likely Than Oncologists to Obtain Detailed Family History of Colorectal Cancer

– Interactive Voice Response System Just as Effective as Nurse Call for Endoscopy Completion

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.